AU2252101A - New synthesis of SPLA2 inhibitors - Google Patents

New synthesis of SPLA2 inhibitors

Info

Publication number
AU2252101A
AU2252101A AU22521/01A AU2252101A AU2252101A AU 2252101 A AU2252101 A AU 2252101A AU 22521/01 A AU22521/01 A AU 22521/01A AU 2252101 A AU2252101 A AU 2252101A AU 2252101 A AU2252101 A AU 2252101A
Authority
AU
Australia
Prior art keywords
new synthesis
spla2 inhibitors
spla2
inhibitors
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22521/01A
Inventor
Douglas Wade Beight
Jason Scott Sawyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2252101A publication Critical patent/AU2252101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22521/01A 1999-12-16 2000-12-11 New synthesis of SPLA2 inhibitors Abandoned AU2252101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17123699P 1999-12-16 1999-12-16
US60171236 1999-12-16
PCT/US2000/032446 WO2001044182A2 (en) 1999-12-16 2000-12-11 New synthesis of spla2 inhibitors

Publications (1)

Publication Number Publication Date
AU2252101A true AU2252101A (en) 2001-06-25

Family

ID=22623044

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22521/01A Abandoned AU2252101A (en) 1999-12-16 2000-12-11 New synthesis of SPLA2 inhibitors

Country Status (2)

Country Link
AU (1) AU2252101A (en)
WO (1) WO2001044182A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP5406716B2 (en) 2006-08-07 2014-02-05 アイアンウッド ファーマシューティカルズ インコーポレイテッド Indole compounds
CN101838232B (en) * 2009-07-07 2012-02-22 爱斯医药科技(南京)有限公司 Preparation method for varespladib
KR20120117905A (en) 2010-01-28 2012-10-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Compositions and methods for enhancing proteasome activity
AR084433A1 (en) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc FAAH INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CN103635230B (en) 2011-05-12 2017-10-31 普罗蒂斯特斯治疗公司 Albumen homeostasis conditioning agent
WO2014116228A1 (en) 2013-01-25 2014-07-31 President And Fellows Of Harvard College Usp14 inhibitors for treating or preventing viral infections
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds

Also Published As

Publication number Publication date
WO2001044182A2 (en) 2001-06-21
WO2001044182A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU3771100A (en) Synthesis of epothilones
AU6762400A (en) Inhibitors of factor xa
AU5283800A (en) Inhibitors of factor xa
AU5283700A (en) Inhibitors of factor xa
AU5283900A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
IL149118A0 (en) Inhibitors of neuraminidases
AU6111000A (en) Inhibitors of viral helcase
AU3565999A (en) Synthesis of azetidine derivatives
AU2557500A (en) Methods of making compounds
AU5283600A (en) Inhibitors of factor xa
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU5331499A (en) Indole spla2 inhibitors
AU2252101A (en) New synthesis of SPLA2 inhibitors
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
WO2000001393A8 (en) OLIGONUCLEOTIDE INHIBITORS OF bcl-xL
AU2002306734A1 (en) Inhibitors of plasmepsins
AU5587200A (en) Synthesis of substituted amidines
AU2373600A (en) Novel spla2 inhibitors
AU2050001A (en) Synthesis of indole-containing spla2 inhibitors
AU2002214038A1 (en) Inhibitors of transglutaminases
AU8005100A (en) Inhibitors of neuraminidases
AU2001252922A1 (en) Azide cyclization-based synthesis and intermediates for spla2 inhibitors
AU2252201A (en) Carbon monoxide-based synthesis of spla2 inhibitors
AU4021700A (en) Methods of use of beta1-integrin inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase